Quest Diagnostics Incorporated (DGX) stock news · P/E 25, rev $11.04B
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
This DGX news page leads with what Quest Diagnostics Incorporated filed — not a scraped headline mill.
No cached 8-K sentence for DGX yet. We will not pad this page with generic market recap.
Latest reported DGX revenue for 2025-12-31 was $11.04B. Net income was $992.0M. Revenue was up 11.8% from 2024-12-31 to 2025-12-31. DGX currently screens at market cap $19.94B and trailing P/E 24.9.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DGX stock page; for the tape open the quote page.
DGX stock news FAQ
What are DGX's latest revenue and net income?
Latest cached Quest Diagnostics Incorporated (DGX) revenue for Dec 31, 2025 was $11.04B. Net income was $992.0M. Statements: https://lician.com/financials/dgx
How did DGX revenue change from the prior cached period?
Cached Quest Diagnostics Incorporated (DGX) revenue was up 11.8% from $9.87B (Dec 31, 2024) to $11.04B (Dec 31, 2025). Statements: https://lician.com/financials/dgx
What is DGX's P/E ratio?
Quest Diagnostics Incorporated (DGX) trailing P/E is 24.9 on the latest cached fundamentals snapshot.
What is DGX's market cap?
Quest Diagnostics Incorporated (DGX) market cap is $19.94B on the latest cached fundamentals snapshot.
What kind of company is DGX?
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Where is DGX stock news listed?
Cached stock news for Quest Diagnostics Incorporated (DGX) is listed at https://lician.com/news/dgx. Filings: https://lician.com/sec/dgx
Not investment advice.